LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION

The Lancet

Volumn 332, Issue 8606, 1988, Pages 298-302

  Lok, AnnaS F ^a   Wu, Pui Chee ^a   Lai, Ching Lung ^a   Leung, ElsieK Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; RECOMBINANT ALPHA2 INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ALOPECIA; ANOREXIA; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; CHINA; CLINICAL TRIALS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INTERFERON TYPE I; MALE; MIDDLE AGE; MONGOLOID RACE; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T; VIRUS REPLICATION;

EID: 0023759015     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(88)92355-0     Document Type: Article

References (25)

1. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication
2. Recombinant leukocyte interferon treatment of chronic hepatitis B
3. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection
4. Lymphoblastoid interferon therapy of chronic HBV infection A comparison of 12 vs 24 weeks of thrice weekly treatment
5. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study
6. Transmission of HBsAg from mother to infant in four ethnic groups
7. Prevelance of hepatitis B e antigen and its antibody in various HBsAg carrier populations
8. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infecticii
9. Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy
10. Reactivation of hepatitis B after transplantation operations
11. Reactivation of hepatitis B virus infection in two patients immunofluorescence studies of liver tissue
12. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy
13. Spontaneous reactivation of chronic hepatitis B virus infection
14. Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis
15. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis
16. Discordance of hepatitis B e antigen/antibody and hepatitis B virus deoxyribonucleic acid in serum
17. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon
18. 2-interferon in Chinese HBsAg-carrier children
19. Antiviral treatment of chronic hepatitis B virus infection I Changes in viral markers with interferon combined with adenine arabinoside
20. Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease
21. Diminished responsiveness of male homosexual chronic hepatitis B virus earners with HTLV III antibodies to recombinant α-interferon
22. Central nervous system toxicity of interferon
23. Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer
24. Interferons as mediators of psychiatric morbidity An investigation in a trial of recombinant α-interferon in hepatitis-B carriers
25. Neurotoxic and other side effects of high-dose interferon in amyotrophic lateral sclerosis